The Cannabis, Mental Health, and Substance Use Health: Research Knowledge Exchange Event Summary Report presents the findings and themes discussed at an event jointly hosted by CCSA (Canadian Centre on Substance Use and Addiction) and the Mental Health Commission of Canada. With funding from Health Canada, the two organizations supported approximately 70 research teams in exploring the potential benefits, harms, and risks of cannabis on substance use health and mental health. The event provided a platform for these research teams to share their project results, observations, and experiences...
SAMHSA report discusses the evidence supporting the effectiveness of screening, brief intervention, and referral to treatment (SBIRT) as a comprehensive approach, as well as for the implementation and effectiveness of the individual components of SBIRT for different behavioural health conditions.
The report describes briefly the underlying research that has been conducted in the prevention and early intervention of risky alcohol, substance abuse and tobacco consumption, as well as commonly reported mental health problems, and describes existing studies/models for specific populations and...
The ASSIST package, which consists of a brief questionnaire, a guide for health professionals on how to use the questionnaire in detecting and responding to substance use and also a self-help manual for cutting down or stopping substance use, is the result of more than 10-years work by WHO and an international group of researchers in the framework of the WHO ASSIST project. It is WHO’s response to the growing demand for guidance on how to best manage problems of substance use in non specialist health care settings. This approach, quick and easy to learn, useful for all substances including...
Call for Research Poster Abstract Submissions and Travel Award Requests
Submission Deadline: January 14, 2024
Present your international drug use and addiction research during the 2024 NIDA International Forum, which will be held June 14–17, 2024, in Montreal, Canada.
The NIDA International Program invites research poster abstract submissions and travel award applications from researchers around the world. Join for the Forum research symposium, interactive workshops, the poster session, and networking activities.
Recent research has revealed an increase in child hospitalisations resulting from accidental cannabis poisoning in various regions of Canada. Toddlers find cannabis edibles enticing due to their resemblance to common treats like candies, chocolates, or baked goods. Incidents of cannabis poisoning predominantly occur within households. It is imperative to emphasise the potential harm cannabis products can pose to children and the necessity of secure storage.
The Canadian Centre on Substance Use and Addiction (CCSA) initiated a public awareness campaign through its social media platforms. We...
Эта публикация отвечает на некоторые из наиболее часто задаваемых вопросов, возникающих в ходе дискуссий о законодательстве о каннабисе. В то время как основное внимание уделяется использованию каннабиса в рекреационных целях, соответствующее законодательство для других целей, включая медицинские и коммерческие продукты, полученные из каннабиса, такие как косметика, оздоровительные продукты и продукты питания, включено для обеспечения необходимого контекста для различных политических инициатив.
Мероприятие организовано совместно Отделом гражданского общества Управления Организации Объединенных Наций по наркотикам и преступности (УНП ООН) и Венским комитетом НПО по наркотикам (VNGOC). Г-жа Хлоя Карпиентье (руководитель Секции...
Из всех запрещенных веществ каннабис выделяется как наиболее широко культивируемый, продаваемый и неправильно используемый. Он оказывает значительное влияние на тело и разум человека, изменяя сенсорное восприятие, настроение, когнитивные способности, координацию движений и чувство себя и времени. В этом списке для чтения вы можете узнать больше о каннабисе и употреблении каннабиса. Вы также можете посетить сеть ISSUP, посвященную этой теме , для дальнейшего чтения материалов и ресурсов.
Hasin, D., & Walsh, C. (2020). Cannabis use, cannabis use disorder, and comorbid psychiatric illness: a narrative review. Journal of Clinical Medicine, 10(1), 15.
Abstract
As attitudes toward cannabis, its legal status, and patterns of use continue to evolve, the landscape surrounding this substance is in a constant state of flux. Against this backdrop, this review aims to provide an up-to-date overview of the literature on the comorbidity of cannabis use and cannabis use disorder (CUD) with other substance use and psychiatric disorders.
Results:
A strong body of literature shows associations between cannabis use and CUD with other drug use, psychosis, mood disorders, anxiety disorders, and personality disorders.
Belete, H., Mekonen, T., Espinosa, D. C., Ambaw, F., Connor, J., Chan, G., ... & Leung, J. (2023). Cannabis use in Sub‐Saharan Africa: a systematic review and meta‐analysis. Addiction.
Абстрактный
Предыстория и цели
Наиболее доступные данные о распространенности употребления каннабиса получены из демографических обследований, проведенных в странах с высоким уровнем дохода в Северной Америке, Океании и Европе. Меньше известно о распространенности употребления каннабиса в Африке. Этот систематический обзор был направлен на обобщение общего потребления каннабиса на уровне населения в странах Африки к югу от Сахары с 2010 года.
Результаты
Исследование включало 53 исследования и включало 13 239 участников.
Среди подростков пожизненная, 12-месячная и 6-месячная...
Mills, L., Dunlop, A., Montebello, M. et al. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Subst Abuse Treat Prev Policy 17, 67 (2022).
Introduction
There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (CUD), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes.
Method
Bayesian multiple regression models were used to examine the impact of age, gender, duration of regular cannabis use, daily quantity of...
Mills, L., Dunlop, A., Montebello, M. et al. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Subst Abuse Treat Prev Policy 17, 67 (2022). https://doi.org/10.1186/s13011-022-00493-z
Introduction and aims
There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (CUD), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes.
Method
Bayesian multiple regression models were used to examine the impact of age, gender, duration of regular cannabis use, daily...
Imtiaz, S., Wells, S., Rehm, J. et al. Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020. Subst Abuse Treat Prev Policy 17, 14 (2022). https://doi.org/10.1186/s13011-022-00441-x
The novel coronavirus disease (COVID-19) pandemic has resulted in substantial burden of disease in Canada. Daily cannabis use is most strongly implicated in the cannabis-attributable burden of disease. In the context of the novel coronavirus disease (COVID-19) pandemic in Canada, the trends were characterised in daily cannabis use in the overall sample and various population subgroups, and examined risk characteristics associated with daily cannabis use.
The specific objectives of this study were as follows:
Characterise trends in daily cannabis use in the overall sample and various...
Ngarachu, E.W., Kiburi, S.K., Owiti, F.R. et al. The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya. Subst Abuse Treat Prev Policy 17, 12 (2022). https://doi.org/10.1186/s13011-022-00437-7
Каннабис является наиболее широко используемым запрещенным веществом в мире, с глобальной распространенностью 4% среди людей в возрасте от 15 до 64 лет и недавней тенденцией к росту употребления. Употребление каннабиса может иметь негативные последствия для здоровья, такие как нарушение развития нервной системы, повышенный риск наркомании и злоупотребления другими наркотиками, когнитивные нарушения, низкий уровень образования и повышенный риск психических заболеваний, таких как психоз, депрессия и тревожные расстройства. Употребление каннабиса во время метадоновой терапии может оказать...
Carlini BH, Garrett S, Firth C, Pinsky I. Cannabis Industry Marketing Violations in Washington State, 2014-2019. J Stud Alcohol Drugs. 2022 Jan;83(1):18-26. PMID: 35040756.
Abstract
Objective: The purpose of this study was to describe marketing violations from the cannabis industry in Washington State.
Method: The study team obtained records of all Washington State cannabis marketing violations from October 2014 to September 2015, immediately following the legal cannabis market opening, and May 2017 to July 2019. A code book was developed based on the Washington State regulations related to marijuana advertising. Each marketing violation was coded according to ad characteristics including ad size, location, or type; content; business practices; and lack of...